[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.149.128. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Download PDF
Figure. Unadjusted pooled survival curves among the vaccinated study population. Outcomes include influenza-like illness (A); hospitalization for influenza/pneumonia (B); and death (C). In matched years, vaccination is expected to be effective in preventing influenza-related outcomes; in mismatched years, the expected effect is minimal.

Figure. Unadjusted pooled survival curves among the vaccinated study population. Outcomes include influenza-like illness (A); hospitalization for influenza/pneumonia (B); and death (C). In matched years, vaccination is expected to be effective in preventing influenza-related outcomes; in mismatched years, the expected effect is minimal.

Table 1. Description of Study Cohortsa
Table 1. Description of Study Cohortsa
Table 2. Description of Influenza Seasonsa
Table 2. Description of Influenza Seasonsa
Table 3. Estimates of Vaccine Effectiveness Comparing Vaccinated vs Unvaccinated Populations by Year
Table 3. Estimates of Vaccine Effectiveness Comparing Vaccinated vs Unvaccinated Populations by Year
Table 4. RHR Estimates of Vaccine Effectiveness by Comparing Matched vs Mismatched Years Among Vaccinated vs Unvaccinated Populations
Table 4. RHR Estimates of Vaccine Effectiveness by Comparing Matched vs Mismatched Years Among Vaccinated vs Unvaccinated Populations
1.
Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population.  Arch Intern Med. 2005;165(3):265-272PubMedArticle
2.
Eickhoff TC. Immunization against influenza: rationale and recommendations.  J Infect Dis. 1971;123(4):446-454PubMedArticle
3.
Vogtländer NPJ, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus ADME. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.  Vaccine. 2004;22(17-18):2199-2201PubMedArticle
4.
Brydak LB, Roszkowska-Blaim M, Machala M, Leszczyńska B, Sieniawska M. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases.  Vaccine. 2000;18(28):3280-3286PubMedArticle
5.
Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.  Lancet Infect Dis. 2009;9(8):493-504PubMedArticle
6.
Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ. Influenza vaccine delivery and effectiveness in end-stage renal disease.  Kidney Int. 2003;63(2):738-743PubMedArticle
7.
Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly.  N Engl J Med. 2007;357(14):1373-1381PubMedArticle
8.
Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease.  Ann Intern Med. 1999;130(5):397-403PubMed
9.
Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.  N Engl J Med. 2003;348(14):1322-1332PubMedArticle
10.
Jackson LA, Nelson JC, Benson P,  et al.  Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors.  Int J Epidemiol. 2006;35(2):345-352PubMedArticle
11.
Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors.  Int J Epidemiol. 2006;35(2):337-344PubMedArticle
12.
Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study.  Lancet. 2008;372(9636):398-405PubMedArticle
13.
Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.  Lancet Infect Dis. 2007;7(10):658-666PubMedArticle
14.
Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older.  Vaccine. 2010;28(45):7267-7272PubMedArticle
15.
Centers for Disease Control and Prevention.  Update: influenza activity—United States and worldwide, 1997-98 season, and composition of the 1998-99 influenza vaccine.  MMWR Morb Mortal Wkly Rep. 1998;47(14):280-284PubMed
16.
Centers for Disease Control and Prevention.  Update: influenza activity—United States, 1997-98 season.  MMWR Morb Mortal Wkly Rep. 1998;47(10):196-200PubMed
17.
Bridges CB, Thompson WW, Meltzer MI,  et al.  Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial.  JAMA. 2000;284(13):1655-1663PubMedArticle
18.
Centers for Disease Control and Prevention.  Update: influenza activity—United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine.  MMWR Morb Mortal Wkly Rep. 1999;48(18):374-378PubMed
19.
Centers for Disease Control and Prevention.  Update: influenza activity—United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine.  MMWR Morb Mortal Wkly Rep. 2000;49(17):375-381PubMed
20.
Centers for Disease Control and Prevention.  Update: influenza activity—United States and worldwide, 2001-02 season, and composition of the 2002-03 influenza vaccine.  MMWR Morb Mortal Wkly Rep. 2002;51(23):503-506PubMed
21.
Centers for Disease Control and Prevention.  Update: influenza activity—United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine.  MMWR Morb Mortal Wkly Rep. 2001;50(22):466-479PubMed
22.
Lindsay L, Jackson LA, Savitz DA,  et al.  Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women.  Am J Epidemiol. 2006;163(9):838-848PubMedArticle
23.
Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ. An improved comorbidity index for outcome analyses among dialysis patients.  Kidney Int. 2010;77(2):141-151PubMedArticle
24.
Cox DR. Regression models and life tables.  J R Stat Soc B. 1972;34:187-220
25.
Efron B. The efficiency of Cox's likelihood function for censored data.  J Am Stat Assoc. 1977;72(359):557-565
26.
US Renal Data System.  USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010
27.
Brookhart MA, Patrick AR, Dormuth C,  et al.  Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect.  Am J Epidemiol. 2007;166(3):348-354PubMedArticle
28.
Fernández-Fresnedo G, Ramos MA, González-Pardo MC, de Francisco ALM, López-Hoyos M, Arias M. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2.  Nephrol Dial Transplant. 2000;15(4):502-510PubMedArticle
29.
Girndt M, Sester M, Sester U, Kaul H, Köhler H. Molecular aspects of T- and B-cell function in uremia.  Kidney Int Suppl. 2001;(78):S206-S211PubMed
30.
Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias.  Am J Epidemiol. 2009;170(5):650-656PubMedArticle
31.
Dikow R, Eckerle I, Ksoll-Rudek D,  et al.  Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.  Am J Kidney Dis. 2011;57(5):716-723PubMedArticle
Original Investigation
Apr 9, 2012

Influenza Vaccine Effectiveness in Patients on HemodialysisAn Analysis of a Natural Experiment

Author Affiliations

Author Affiliations: Department of Epidemiology, Gillings School of Global Public Health (Ms McGrath and Drs Cole, Weber, Stürmer, and Brookhart), Divisions of Nephrology and Hypertension (Dr Kshirsagar) and Infectious Diseases (Dr Weber), Department of Medicine, and The Cecil G. Sheps Center for Health Services Research (Dr Wang), University of North Carolina, Chapel Hill.

Arch Intern Med. 2012;172(7):548-554. doi:10.1001/archinternmed.2011.2238
×